CDK2 and melanoma: These results agree with the data described in a different melanoma model, where HO-1 was reported to interact with B-Raf, eventually triggering the B-RAF-ERK1/2 signaling pathway leading to CDK2/cyclin E activation, thus promoting melanoma proliferation [32,33].